Xylem Liabilities And Stockholders Equity from 2010 to 2024

XYL Stock  USD 127.69  0.68  0.54%   
Xylem Liabilities And Stockholders Equity yearly trend continues to be quite stable with very little volatility. Liabilities And Stockholders Equity may rise above about 16.9 B this year. Liabilities And Stockholders Equity is the total of all liabilities and equity in the company, which should equal Xylem's total assets according to the accounting equation. View All Fundamentals
 
Liabilities And Stockholders Equity  
First Reported
2010-12-31
Previous Quarter
15.8 B
Current Value
16 B
Quarterly Volatility
3.4 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Xylem financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Xylem's main balance sheet or income statement drivers, such as Depreciation And Amortization of 457.8 M, Interest Expense of 57.9 M or Selling General Administrative of 1.2 B, as well as many indicators such as Price To Sales Ratio of 1.9, Dividend Yield of 0.0129 or PTB Ratio of 3.08. Xylem financial statements analysis is a perfect complement when working with Xylem Valuation or Volatility modules.
  
Check out the analysis of Xylem Correlation against competitors.

Latest Xylem's Liabilities And Stockholders Equity Growth Pattern

Below is the plot of the Liabilities And Stockholders Equity of Xylem Inc over the last few years. It is the total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation. Xylem's Liabilities And Stockholders Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Xylem's overall financial position and show how it may be relating to other accounts over time.
Liabilities And Stockholders Equity10 Years Trend
Slightly volatile
   Liabilities And Stockholders Equity   
       Timeline  

Xylem Liabilities And Stockholders Equity Regression Statistics

Arithmetic Mean7,486,506,667
Geometric Mean6,658,649,077
Coefficient Of Variation54.24
Mean Deviation2,773,141,333
Median6,860,000,000
Standard Deviation4,061,039,968
Sample Variance16492045.6T
Range14.4B
R-Value0.86
Mean Square Error4536968.4T
R-Squared0.74
Significance0.000035
Slope783,554,286
Total Sum of Squares230888638.7T

Xylem Liabilities And Stockholders Equity History

202416.9 B
202316.1 B
2022B
20218.3 B
20208.8 B
20197.7 B
20187.2 B

About Xylem Financial Statements

Xylem investors utilize fundamental indicators, such as Liabilities And Stockholders Equity, to predict how Xylem Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Liabilities And Stockholders Equity16.1 B16.9 B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Xylem Inc is a strong investment it is important to analyze Xylem's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Xylem's future performance. For an informed investment choice regarding Xylem Stock, refer to the following important reports:
Check out the analysis of Xylem Correlation against competitors.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Industrial Machinery & Supplies & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xylem. If investors know Xylem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xylem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.413
Dividend Share
1.41
Earnings Share
3.48
Revenue Per Share
34.788
Quarterly Revenue Growth
0.013
The market value of Xylem Inc is measured differently than its book value, which is the value of Xylem that is recorded on the company's balance sheet. Investors also form their own opinion of Xylem's value that differs from its market value or its book value, called intrinsic value, which is Xylem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xylem's market value can be influenced by many factors that don't directly affect Xylem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xylem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Xylem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xylem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.